Infineon Technologies AG (NYSE:IFX) – Significant appreciation in common stock price since our previous update report.
Infineon Technologies AG’s (Infineon) common stock has appreciated significantly since our 1Q 09 update report, including a stock price appreciation of 11.3% in a single trading session on 17 April 2009, reflecting the impact of news that the company was seeking financial aid from the German government’s fund, set up to help companies in the current downturn, as well as the company’s announcement of the extension of its alliance with IBM Corp., Global Foundries Inc., Samsung Electronics Co., Ltd., STMicroelectronics N.V. and Chartered Semiconductor Manufacturing Ltd. to jointly develop 28-nanometer, high-k metal gate, low-power bulk CMOS process technology. The stock price also surged 8.6% in a single trading session on 22 April 2009, after the company announced a collaboration with Nokia Corporation (Nokia). Nevertheless, we maintain our SELL rating for the stock, primarily based on a lack of visibility regarding a potential investor for Qimonda and on possible aid from the German government, in the absence of which the company’s debt obligations remain a significant concern. We will reassess the Infineon common stock rating and target price after the company announces its 2Q 09 results. We maintain our SELL rating for the ADR based on our fundamental outlook and negative currency impact. Today the company has delisted its ADR from the NYSE. The ADR is being maintained as a ‘Level I’ program, and has been listed on the over-the-counter market OTCQX, with the ticker IFNNY.PK. We will reassess the ADR rating and target price for Infineon after the company announces its 2Q 09 results.
Read the full report free of charge with free to view access to institutional-quality research on 400 companies and over 700 stocks at www.researchoracle.com or purchase a pdf of the full report from the Alacra store
Disclaimer Independent International Investment Research PLC supplies this research via Pronet Analytics.com Ltd. (’Pronet’). Pronet is Regulated and Authorized by the Financial Services Authority (FSA) and registered with the Securities Exchange Commission (SEC). You are reminded that investment advice provided by Pronet is for your general information and use and is not intended to address your particular requirements. Any advice or recommendations contained in this report may not be suitable for you and are not intended to be relied upon by you in the making (or refraining from making) any specific investment or other decision. Such decisions should only be made on the basis of independent advice from an appropriately qualified adviser. Pronet Analytics.com Ltd. and Independent Financial Markets Research Ltd. are subsidiaries of Independent International Investment Research PLC (the ‘Group’). Research analysts working for the Group are subject to stringent confidentiality and security policies and are located in secure-access premises which may be in the proximity of professionals conducting similar work for other firms. The Group is not nor has been nor will be engaged in investment banking and does not make markets in any of the securities covered in this report or have any investment banking relationship with the firm whose security is covered in this report. No employee or contractor of the Group is permitted to personally buy or sell stock in the company covered in this report, and neither the analysts responsible for this report nor any related household members are officers, directors, or advisory board members of any covered company. No one at a covered company is on the Board of Directors of the Group or any of its affiliates. This report is not a solicitation to buy or sell any security and past performance is no guarantee of future results. Copyright © 2009 Independent International Investment Research PLC. All rights reserved.
937 views.
Categories: Business, Equities, Information Technology, North America Business, Equity Research, Finance, IFXGn.DE, Infineon Technologies AG, NYSE:IFX, Research Oracle

